Benjamin Lightburn Combines Hard Extraction And Drug Discovery Technology To Harness The Healing Potential Of Natural Psychedelics

Welcome to another episode of Action and Ambition. Benjamin Lightburn is the CEO and Co-Founder of Filament Health, which develops only natural psychedelic drugs. Filament Health is developing a platform to help treat mental health conditions using GMP-compliant and FDA-approved psychedelic extracts derived from lab-grown and regeneratively harvested plants. Filament Health has a powerful natural psychedelics intellectual property portfolio based on novel extraction and purification methods, and experienced botanical extraction management team, a Health Canada Dealer's License for all-natural psychedelics, and in-house GMP manufacturing capabilities. The filament is the bedrock upon which a fast-expanding drug discovery pipeline is built. Sounds interesting, right? Then tune in to find out more about this!